Rodrigo A Guzmán-Venegas1, Oscar F Araneda1, Rony A Silvestre2. 1. Laboratorio Integrativo de Biomecánica y Fisiología del Esfuerzo (LIBFE), Kinesiology School, Faculty of Medicine, Universidad de los Andes, Santiago, Chile. 2. Centro de Estudios del Movimiento Humano, Kinesiology School, Faculty of Medicine, Universidad Mayor, Santiago, Chile.
Abstract
BACKGROUND: Botulinum toxin (BTX) acts on the neuromuscular junction which can be located by the innervation zone (IZ). Clinically, the motor point (MP) is homologous to the IZ and it is used as the injection site of BTX. Differences in the effectiveness of the application of BTX between MP and IZ locations have been determined. OBJECTIVE: Compare the location of the MP obtained using electrical stimulation and the location of the IZ using a linear surface electrodes array on the biceps brachii muscle. METHODS: The biceps brachii muscle of twenty men was assessed. The MP was located using the torque measurement generated by electrical stimulation. The IZ was detected using a linear surface electrodes array. RESULTS: A difference between the MP and the IZ positions (75.8 vs. 86.5mm, delta 10.7 mm; p=0.003, post-hoc power 0.89) was observed. DISCUSSION: The magnitude of the difference between the MP and the IZ may be clinically relevant. The IZ location using surface electromyography as a guide to optimize BTX injection is proposed.
BACKGROUND: Botulinum toxin (BTX) acts on the neuromuscular junction which can be located by the innervation zone (IZ). Clinically, the motor point (MP) is homologous to the IZ and it is used as the injection site of BTX. Differences in the effectiveness of the application of BTX between MP and IZ locations have been determined. OBJECTIVE: Compare the location of the MP obtained using electrical stimulation and the location of the IZ using a linear surface electrodes array on the biceps brachii muscle. METHODS: The biceps brachii muscle of twenty men was assessed. The MP was located using the torque measurement generated by electrical stimulation. The IZ was detected using a linear surface electrodes array. RESULTS: A difference between the MP and the IZ positions (75.8 vs. 86.5mm, delta 10.7 mm; p=0.003, post-hoc power 0.89) was observed. DISCUSSION: The magnitude of the difference between the MP and the IZ may be clinically relevant. The IZ location using surface electromyography as a guide to optimize BTX injection is proposed.
Authors: Tiina Rekand; Bo Biering-Sörensen; Jun He; Ole Jakob Vilholm; Peter Brøgger Christensen; Trandur Ulfarsson; Roger Belusa; Torbjörn Ström; Peter Myrenfors; Pascal Maisonobe; Torben Dalager Journal: BMJ Open Date: 2019-05-05 Impact factor: 2.692